| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ffb0259eb5c7ba9c5f84877ca1e6e81 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddc2cdb283fe4b8ac2c679728d46dde5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ef46a1afc2a93a2806ee61f68042b02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_802f35963795f7ac9874e34ef4c2a26a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13b55360f2ff9db8a0d6eba5b27eb992 |
| publicationDate |
2015-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015190474-A1 |
| titleOfInvention |
Use of long-acting glp-1 peptides |
| abstract |
The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022272019-A3 |
| priorityDate |
2012-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |